HECHT BETH (See Remarks) sold 1.2% of their position (16.67K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $123.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/13/2025ACC: 0001652410-25-000003
Officer· See Remarks
Since Oct 2021
-16.67K
Net shares
Net seller
$123.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
16.67K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−16.67K
Price / share
$7.40
Trade value
$123.30K
% of position
1.2%
11/11/2025
1.35M→1.34M
Total
Net shares
−16.67K
Net value
-$123.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/11/2025 | S · Sale | −16.67K | $7.40 | $123.30K | 1.2% | 1.35M | 1.34M |
| Total | −16.67K | -$123.30K | ||||||
Derivative Transactions0
No derivative transactions reported